REFERENCES

1. Balali-Mood, M.; Naseri, K.; Tahergorabi, Z.; Khazdair, M. R.; Sadeghi, M. Toxic mechanisms of five heavy metals: mercury, lead, chromium, cadmium, and arsenic. Front. Pharmacol. 2021, 12, 643972.

2. Järup, L. Hazards of heavy metal contamination. Br. Med. Bull. 2003, 68, 167-82.

3. Lentini, P.; Zanoli, L.; Granata, A.; Signorelli, S. S.; Castellino, P.; Dell’Aquila, R. Kidney and heavy metals - the role of environmental exposure (Review). Mol. Med. Rep. 2017, 15, 3413-9.

4. Barbier, O.; Jacquillet, G.; Tauc, M.; Cougnon, M.; Poujeol, P. Effect of heavy metals on, and handling by, the kidney. Nephron. Physiol. 2005, 99, p105-10.

5. Orr, S. E.; Bridges, C. C. Chronic kidney disease and exposure to nephrotoxic metals. Int. J. Mol. Sci. 2017, 18, 1039.

6. Schnellmann, R. G. Toxic responses of the kidney. In Casarett & Doull’s Essentials of Toxicology; McGraw Hill; 2021. https://accesspharmacy.mhmedical.com/content.aspx?bookid=3000&sectionid=252314136. (accessed 2026-04-20).

7. Aaseth, J.; Alexander, J.; Alehagen, U.; et al. The aging kidney - as influenced by heavy metal exposure and selenium supplementation. Biomolecules 2021, 11, 1078.

8. de Wit-Bos, L.; Chen, W.; van den Brand, A.; et al. Risk assessment of the mixture of cadmium and lead for people over fifty. 2024. https://rivm.openrepository.com/handle/10029/627888. (accessed 2026-04-20).

9. Wang, R.; Long, T.; He, J.; et al. Associations of multiple plasma metals with chronic kidney disease in patients with diabetes. Ecotoxicol. Environ. Saf. 2022, 244, 114048.

10. Wu, W.; Zhang, K.; Jiang, S.; et al. Association of co-exposure to heavy metals with renal function in a hypertensive population. Environ. Int. 2018, 112, 198-206.

11. Bobb, J. F.; Valeri, L.; Claus Henn, B.; et al. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics 2015, 16, 493-508.

12. Bobb, J. F.; Claus Henn, B.; Valeri, L.; Coull, B. A. Statistical software for analyzing the health effects of multiple concurrent exposures via Bayesian kernel machine regression. Environ. Health. 2018, 17, 67.

13. Hou, J.; Yin, W.; Li, P.; et al. Joint effect of polycyclic aromatic hydrocarbons and phthalates exposure on telomere length and lung function. J. Hazard. Mater. 2020, 386, 121663.

14. Yu, L.; Yang, M.; Cheng, M.; et al. Associations between urinary phthalate metabolite concentrations and markers of liver injury in the US adult population. Environ. Int. 2021, 155, 106608.

15. Yu, L.; Liu, W.; Wang, X.; et al. A review of practical statistical methods used in epidemiological studies to estimate the health effects of multi-pollutant mixture. Environ. Pollut. 2022, 306, 119356.

16. Zhang, Y.; Dong, T.; Hu, W.; et al. Association between exposure to a mixture of phenols, pesticides, and phthalates and obesity: comparison of three statistical models. Environ. Int. 2019, 123, 325-36.

17. Manniën, J.; Ledderhof, T.; Verspaget, H. W.; et al. The Parelsnoer Institute: A national network of standardized clinical biobanks in the Netherlands. Open. J. Bioresour. 2017, 4, 3.

18. Navis, G. J.; Blankestijn, P. J.; Deegens, J.; et al.; BIND-NL investigators. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol. Dial. Transplant. 2014, 29, 1145-50.

19. Stevens, P. E.; Levin, A.; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 2013, 158, 825-30.

20. Levey, A. S.; Stevens, L. A.; Schmid, C. H.; et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150, 604-12.

21. WHO. Regional Office for the Western Pacific. Noncommunicable disease education manual for primary health care professionals and patients. 2017. https://iris.who.int/handle/10665/254746. (accessed 2026-04-20).

22. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2025. Diabetes. Care. 2025, 48, S27-49.

23. Grundy, S. M.; Stone, N. J.; Bailey, A. L.; et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019, 73, e285-350.

24. CDC. National Center for Environmental Health (U.S.), Division of Laboratory Sciences, National Health and Nutrition Examination Survey (U.S.). Fourth National Report on human exposure to environmental chemicals. 2009. https://stacks.cdc.gov/view/cdc/21813. (accessed 2026-04-20).

25. Gil, F.; Hernández, A. F. Toxicological importance of human biomonitoring of metallic and metalloid elements in different biological samples. Food. Chem. Toxicol. 2015, 80, 287-97.

26. Health Canada. Third report on human biomonitoring of environmental chemicals in Canada. 2015. https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/ewh-semt/alt_formats/pdf/pubs/contaminants/chms-ecms-cycle3/chms-ecms-cycle3-eng.pdf. (accessed 2026-04-20).

27. Jalili, C.; Kazemi, M.; Cheng, H.; et al. Associations between exposure to heavy metals and the risk of chronic kidney disease: a systematic review and meta-analysis. Crit. Rev. Toxicol. 2021, 51, 165-82.

28. Nguyen, H. D. Interactions between heavy metal mixtures and kidney function: gender-stratified analyses. Expo. Health. 2024, 16, 821-36.

29. Kim, N. H.; Hyun, Y. Y.; Lee, K. B.; et al. Environmental heavy metal exposure and chronic kidney disease in the general population. J. Korean. Med. Sci. 2015, 30, 272-7.

30. Bourgonje, A. R.; Abdulle, A. E.; Bourgonje, M. F.; et al. Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population. Redox. Biol. 2021, 48, 102211.

31. Nan, Y.; Yang, J.; Yang, J.; Wei, L.; Bai, Y. Associations between individual and combined metal exposures in whole blood and kidney function in U.S. adults aged 40 years and older. Biol. Trace. Elem. Res. 2024, 202, 850-65.

32. Hernán, M. A.; Hernández-Díaz, S.; Werler, M. M.; Mitchell, A. A. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am. J. Epidemiol. 2002, 155, 176-84.

33. Devick, K. BKMR plot functions for multiply imputed data. 2019. https://github.com/kdevick/bkmr_MI. (accessed 2026-04-20).

34. Sanders, A. P.; Mazzella, M. J.; Malin, A. J.; et al. Combined exposure to lead, cadmium, mercury, and arsenic and kidney health in adolescents age 12-19 in NHANES 2009-2014. Environ. Int. 2019, 131, 104993.

35. Zhou, T. T.; Hu, B.; Meng, X. L.; et al. The associations between urinary metals and metal mixtures and kidney function in Chinese community-dwelling older adults with diabetes mellitus. Ecotoxicol. Environ. Saf. 2021, 226, 112829.

36. Jin, R.; Zhu, X.; Shrubsole, M. J.; Yu, C.; Xia, Z.; Dai, Q. Associations of renal function with urinary excretion of metals: evidence from NHANES 2003-2012. Environ. Int. 2018, 121, 1355-62.

37. Weaver, V. M.; Kim, N. S.; Jaar, B. G.; et al. Associations of low-level urine cadmium with kidney function in lead workers. Occup. Environ. Med. 2011, 68, 250-6.

38. Buser, M. C.; Ingber, S. Z.; Raines, N.; Fowler, D. A.; Scinicariello, F. Urinary and blood cadmium and lead and kidney function: NHANES 2007-2012. Int. J. Hyg. Environ. Health. 2016, 219, 261-7.

39. Cortinovis, M.; Perico, N.; Ruggenenti, P.; Remuzzi, A.; Remuzzi, G. Glomerular hyperfiltration. Nat. Rev. Nephrol. 2022, 18, 435-51.

40. Chaumont, A.; Nickmilder, M.; Dumont, X.; Lundh, T.; Skerfving, S.; Bernard, A. Associations between proteins and heavy metals in urine at low environmental exposures: evidence of reverse causality. Toxicol. Lett. 2012, 210, 345-52.

41. Akerstrom, M.; Barregard, L.; Lundh, T.; Sallsten, G. The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population. Toxicol. Appl. Pharmacol. 2013, 268, 286-93.

42. Weaver, V. M.; Kotchmar, D. J.; Fadrowski, J. J.; Silbergeld, E. K. Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? J. Expo. Sci. Environ. Epidemiol. 2016, 26, 1-8.

43. Suzuki, K. T.; Mandal, B. K.; Ogra, Y. Speciation of arsenic in body fluids. Talanta 2002, 58, 111-9.

44. Vahter, M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182, 211-7.

45. Carmine, T. C. Non-linear creatinine dilution adjustment of exemplary urine arsenic - Part I: curving the lines. SSRN 2023.

46. Weidemann, D.; Kuo, C. C.; Navas-Acien, A.; Abraham, A. G.; Weaver, V.; Fadrowski, J. Association of arsenic with kidney function in adolescents and young adults: results from the National Health and Nutrition Examination Survey 2009-2012. Environ. Res. 2015, 140, 317-24.

47. Bridges, C. C.; Zalups, R. K. The aging kidney and the nephrotoxic effects of mercury. J. Toxicol. Environ. Health. B. Crit. Rev. 2017, 20, 55-80.

48. de Burbure, C.; Buchet, J. P.; Bernard, A.; et al. Biomarkers of renal effects in children and adults with low environmental exposure to heavy metals. J. Toxicol. Environ. Health. A. 2003, 66, 783-98.

49. Schmidt, I, M.; Srivastava, A.; Sabbisetti, V.; et al.; Chronic Kidney Disease Biomarkers Consortium and the CRIC Study Investigators. Plasma kidney injury molecule 1 in CKD: findings from the Boston Kidney Biopsy cohort and CRIC studies. Am. J. Kidney. Dis. 2022, 79, 231-43.e1.

50. Prozialeck, W. C.; Vaidya, V. S.; Liu, J.; et al. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney. Int. 2007, 72, 985-93.

51. Inker, L. A.; Tighiouart, H.; Coresh, J.; et al. GFR estimation using β-trace protein and β2-microglobulin in CKD. Am. J. Kidney. Dis. 2016, 67, 40-8.

52. Novak, R.; Salai, G.; Hrkac, S.; Vojtusek, I. K.; Grgurevic, L. Revisiting the role of NAG across the continuum of kidney disease. Bioengineering 2023, 10, 444.

53. Randers, E.; Erlandsen, E. J. Serum cystatin C as an endogenous marker of the renal function - a review. Clin. Chem. Lab. Med. 1999, 37, 389-95.

54. Danziger, J.; Dodge, L. E.; Hu, H.; Mukamal, K. J. Susceptibility to environmental heavy metal toxicity among Americans with kidney disease. Kidney360 2022, 3, 1191-6.

55. Schrenk, D.; Bignami, M.; Bodin, L.; et al.; EFSA Panel on Contaminants in the Food Chain (CONTAM). Update of the risk assessment of inorganic arsenic in food. EFSA. J. 2024, 22, e8488.

56. Tamayo-Ortiz, M.; Talayero, M. J.; Farías, P. Lead poisoning. N. Engl. J. Med. 2025, 392, 623-4.

Journal of Environmental Exposure Assessment
ISSN 2771-5949 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/